par Fumagalli, Debora 
;Desmedt, Christine ;Ignatiadis, Michail ;Loi, Sherene ;Piccart-Gebhart, Martine ;Sotiriou, Christos
Référence Journal of the National Cancer Institute. Monographs, 2011, 43, page (124-127)
Publication Publié, 2011
;Desmedt, Christine ;Ignatiadis, Michail ;Loi, Sherene ;Piccart-Gebhart, Martine ;Sotiriou, Christos Référence Journal of the National Cancer Institute. Monographs, 2011, 43, page (124-127)
Publication Publié, 2011
Article révisé par les pairs
| Titre: |
|
| Auteur: | Fumagalli, Debora; Desmedt, Christine; Ignatiadis, Michail; Loi, Sherene; Piccart-Gebhart, Martine; Sotiriou, Christos |
| Informations sur la publication: | Journal of the National Cancer Institute. Monographs, 2011, 43, page (124-127) |
| Statut de publication: | Publié, 2011 |
| Sujet CREF: | Cancérologie |
| MeSH keywords: | Anthracyclines -- therapeutic use |
| Antineoplastic Agents -- therapeutic use | |
| Breast Neoplasms -- drug therapy -- metabolism | |
| Chemotherapy, Adjuvant | |
| Female | |
| Gene Expression Profiling | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Molecular Targeted Therapy | |
| Neoadjuvant Therapy -- methods | |
| Predictive Value of Tests | |
| Prognosis | |
| Randomized Controlled Trials as Topic | |
| Tumor Markers, Biological -- metabolism | |
| Note générale: | Journal Article |
| SCOPUS: ar.k | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1052-6773 |
| info:doi/10.1093/jncimonographs/lgr040 | |
| info:pii/lgr040 | |
| info:scp/84855174024 | |
| info:pmid/22043058 |
